NCT00589082View on ClinicalTrials.gov

DaunoXome + Ara-C vs Daunorubicin + Ara-C in Elderly AML

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

October 31, 2001

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions

AMLElderly

Interventions

DRUG

DaunoXome

DRUG

Daunorubicine

All Listed Sponsors

lead

Gruppo Italiano Malattie EMatologiche dell'Adulto

OTHER

NCT00589082 - DaunoXome + Ara-C vs Daunorubicin + Ara-C in Elderly AML | Biotech Hunter | Biotech Hunter